Senior Editor – Europe
Latest From David Ridley
Procter & Gamble joint venture Clearblue has launched a UK PR campaign aimed at de-stigmatizing the conception pre-pregnancy phase by putting control and confidence back in women’s hands.
HBW Insight Exclusive: Flarin boss Andrew Macmillen on competing with the big OTC incumbents as a lean, innovation-focused company.
HBW Insight Exclusive: A lack of regulatory harmonization, especially with regards to Rx-to-OTC switch, is holding the Asia-Pacific OTC market back, according to APSMI secretary general, Toshi Tominaga.
OTC marketing news from Germany: A hard-won desloratadine launch from Novartis, two new products from Dermapharm, as well as homeopathic and probiotic alternatives from Hevert and Bencard.
Sanofi enters the probiotics space with Buscobiota in the UK, and British probiotics specialist Protexin adds two brain health supplements to its Bio-Kult range.
CBD News Round-Up: Australia Proposes OTC Pathway, First EU Novel Food Validation, COVID Boost For UK Firm
Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.